794 related articles for article (PubMed ID: 29778561)
1. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
Aljenedil S; Ruel I; Watters K; Genest J
J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
[TBL] [Abstract][Full Text] [Related]
2. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.
Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K
Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007
[TBL] [Abstract][Full Text] [Related]
3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
[TBL] [Abstract][Full Text] [Related]
5. Effect of Statin Therapy in 4-Year-Old Dichorionic Diamniotic Twins with Familial Hypercholesterolemia Showing Multiple Xanthomas.
Miyagi Y; Harada-Shiba M; Ohta T
J Atheroscler Thromb; 2016; 23(1):112-7. PubMed ID: 26510755
[TBL] [Abstract][Full Text] [Related]
6. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
7. A case of ezetimibe-effective hypercholesterolemia with a novel heterozygous variant in ABCG5.
Nakano Y; Komiya C; Shimizu H; Mishima H; Shiba K; Tsujimoto K; Ikeda K; Kashimada K; Dateki S; Yoshiura KI; Ogawa Y; Yamada T
Endocr J; 2020 Nov; 67(11):1099-1105. PubMed ID: 32641618
[TBL] [Abstract][Full Text] [Related]
8. Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.
Jelassi A; Slimani A; Jguirim I; Najah M; Abid A; Boughamoura L; Mzid J; Fkih M; Maatouk F; Rouis M; Varret M; Slimane MN
Clin Chim Acta; 2010 May; 411(9-10):735-8. PubMed ID: 20144596
[TBL] [Abstract][Full Text] [Related]
9. Successful pharmacological management of a child with compound heterozygous familial hypercholesterolemia and review of the recent literature.
Sreedharan AV; Pek SLT; Tan TH; Tavintharan S; Yap F
J Clin Lipidol; 2020; 14(5):639-645. PubMed ID: 32800790
[TBL] [Abstract][Full Text] [Related]
10. APOE p.Leu167del mutation in familial hypercholesterolemia.
Awan Z; Choi HY; Stitziel N; Ruel I; Bamimore MA; Husa R; Gagnon MH; Wang RH; Peloso GM; Hegele RA; Seidah NG; Kathiresan S; Genest J
Atherosclerosis; 2013 Dec; 231(2):218-22. PubMed ID: 24267230
[TBL] [Abstract][Full Text] [Related]
11. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.
Raal FJ; Santos RD
Atherosclerosis; 2012 Aug; 223(2):262-8. PubMed ID: 22398274
[TBL] [Abstract][Full Text] [Related]
12. Widespread xanthomas regression by personalized lipid lowering therapy in heterozygous familial hypercholesterolemia.
Sbrana F; Pino BD; Bigazzi F; Sampietro T
Clin Investig Arterioscler; 2024; 36(1):35-37. PubMed ID: 38016879
[TBL] [Abstract][Full Text] [Related]
13. Xanthomas associated with homozygous familial hypercholesterolemia.
Riche DM; East HE
Pharmacotherapy; 2009 Dec; 29(12):1496. PubMed ID: 19947811
[TBL] [Abstract][Full Text] [Related]
14. A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia.
Vergopoulos A; Bajari T; Jouma M; Knoblauch H; Aydin A; Bähring S; Mueller-Myhsok B; Dresel A; Joubran R; Luft FC; Schuster H
Eur J Hum Genet; 1997; 5(5):315-23. PubMed ID: 9412789
[TBL] [Abstract][Full Text] [Related]
15. Homozygous familial hypercholesterolemia: case report of a rare cause of dyslipidemia.
Alves C; Braid Z
Pediatr Endocrinol Diabetes Metab; 2011; 17(3):162-5. PubMed ID: 22027071
[TBL] [Abstract][Full Text] [Related]
16. [Homozygous familial hypercholesterolemia: development and a case illustration].
Choukri M; Laaroussi N; Taheri H; Chabraoui L
Ann Biol Clin (Paris); 2013; 71(1):99-103. PubMed ID: 23396432
[TBL] [Abstract][Full Text] [Related]
17. Familial homozygous hypercholesterolemia: report of two patients and review of the literature.
Sethuraman G; Sugandhan S; Sharma G; Chandramohan K; Chandra NC; Dash SS; Komal A; Sharma VK
Pediatr Dermatol; 2007; 24(3):230-4. PubMed ID: 17542869
[TBL] [Abstract][Full Text] [Related]
18. Coexisting type III hyperlipoproteinemia and familial hypercholesterolemia: a case report.
Sakuma N; Iwata S; Ikeuchi R; Ichikawa T; Hibino T; Kamiya Y; Ohte N; Kawaguchi M; Kunimatsu M; Kawahara H
Metabolism; 1995 Apr; 44(4):460-5. PubMed ID: 7723668
[TBL] [Abstract][Full Text] [Related]
19. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
Feussner G; Dobmeyer J; Nissen H; Hansen TS
Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
